Document is current
Any future updates will be listed below
-
Authors
Park, Jun Won
Curtis, Jeffrey R.
Kim, Min Jung
Lee, Hajeong
Song, Yeong Wook
Lee, Eun Bong https://orcid.org/0000-0003-0703-1208
-
Funding
Funding for this research was provided by:
Korea National Institute of Health (HC17C0069)
- License Information
-
More Information
Article History
Received: 30 May 2019
Accepted: 5 September 2019
First Online: 14 September 2019
Ethics approval and consent to participate
: The study was carried out in accordance with the Declaration of Helsinki and was approved by the institutional review board (IRB) of Seoul National University Hospital [IRB No 0907-062-287]. Consent was waived by the IRB because of the retrospective nature of the study.
: Not applicable
: Eun Bong Lee has acted as a consultant to Pfizer and received research grants from Green Cross Corp, outside the submitted work. Jeffrey R Curtis reports grants and personal fees from AbbVie, grants and personal fees from Amgen, grants and personal fees from BMS, grants and personal fees from Corrona, grants and personal fees from Eli Lilly, grants and personal fees from Myriad, grants and personal fees from Pfizer, grants and personal fees from Janssen, grants and personal fees from Roche, grants and personal fees from Regeneron, and grants and personal fees from UCB, outside the submitted work. The other authors declare that they have no competing interests.
